Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Charcot-Marie-Tooth disease type 2C


Other Names for this Disease
  • Charcot Marie Tooth disease type 2C
  • Charcot-Marie-Tooth disease, axonal, Type 2C
  • CMT 2C
  • Hereditary motor and sensory neuropathy 2 C
  • HMSN 2 C
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Your Question

My wife has Charcot-Marie-Tooth disease type 2C. What is the prognosis for individuals with this condition?

Our Answer

We have identified the following information that we hope you find helpful. If you still have questions, please contact us.

What is Charcot-Marie-Tooth disease type 2C?

Charcot-Marie-Tooth disease (CMT) is a group of progressive disorders that affect the peripheral nerves and result in problems with movement and sensation. [1] In CMT type 2 (CMT2), the motor system is more prominently involved than the sensory system, although both are involved. Individuals with this condition typically have slowly progressive weakness and atrophy of distal muscles in the feet and/or hands usually associated with depressed tendon reflexes and mild or no sensory loss. There is significant clinical overlap with CMT1. The subtypes of CMT2 are similar clinically and distinguished only by molecular genetic findings.[2]  

Charcot-Marie-Tooth disease type 2C (CMT2C) is a very rare form of CMT. Individuals with this condition may have diaphragm or vocal cord paresis in addition to the other problems associated with CMT.[2][3] Mild sensory loss has also been noted in some individuals.[2] CMT type 2C is caused by mutations in the TRPV4 gene on chromosome 12q24.[2][3]

Last updated: 6/3/2011

What is the prognosis for individuals diagnosed with Charcot Marie Tooth disease type 2C (CMT2C)?

Charcot-Marie-Tooth disease (CMT) is a progressive disorder, meaning that it is expected to get worse over time. In general, it is difficult to predict the exact course that the progression is expected to take. For some types of CMT there is natural history information that can guide an average course of the disorder. CMT2C shows quite a bit of phenotypic variability, with marked intrafamilial variability of disease onset and severity. Earlier onset appears to be associated with increased disease severity. Respiratory failure due to intercostal muscle and diaphragm involvement may lead to shortened life expectancy. Reports in the medical literature describe patients who range from nearly asymptomatic to individuals requiring respiratory assistance to those who are wheelchair-bound and in need of assistance in all activities of daily living.[4]
Last updated: 6/3/2011

References